CIK 0001882782 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Odyssey Therapeutics, Inc.
Sign in to watch- Ticker
- ODTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863384382
- Phone
- (212) 841-1000
- Business address
- 51 SLEEPER STREET, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Conversion · Series D Convertible Preferred Stock | −2,657,860 | 0 | ||
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC 10% owner | Option exercise · Series D Warrants (Right to Buy) | −764,312 | 0 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Conversion | +28,698 | 28,698 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Option exercise | +2,963 | 31,661 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Shares withheld for taxes | −17 | $18.00 | $306 | 31,644 |
| 2026-05-11 | LEIDEN JEFFREY M Director | Conversion · Series B Convertible Preferred Stock | −79,166 | 0 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Conversion · Series C Convertible Preferred Stock | −100,000 | 0 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Conversion · Series D Convertible Preferred Stock | −96,002 | 0 | ||
| 2026-05-11 | LEIDEN JEFFREY M Director | Option exercise · Series D Warrants (Right to Buy) | −28,800 | 0 | ||
| 2026-05-11 | Li Nan (LN) Director | Conversion | +1,709,543 | 2,222,405 | ||
| 2026-05-11 | Li Nan (LN) Director | Purchase | +1,111,111 | $18.00 | $20.0M | 3,333,516 |
| 2026-05-11 | Li Nan (LN) Director | Conversion · Series D Convertible Preferred Stock | −16,611,626 | 0 | ||
| 2026-05-11 | Chu Shelley Director | Purchase | +11,111 | $18.00 | $200K | 11,111 |
| 2026-05-11 | Glick Gary D See Remarks | Conversion | +27,386 | 415,973 | ||
| 2026-05-11 | Glick Gary D See Remarks | Conversion · Series C Convertible Preferred Stock | −100,000 | 0 | ||
| 2026-05-11 | Glick Gary D See Remarks | Conversion · Series D Convertible Preferred Stock | −166,116 | 0 | ||
| 2026-05-11 | Opipari Anthony W. See Remarks | Conversion | +6,965 | 6,965 | ||
| 2026-05-11 | Opipari Anthony W. See Remarks | Option exercise | +541 | 7,506 | ||
| 2026-05-11 | Opipari Anthony W. See Remarks | Shares withheld for taxes | −4 | $18.00 | $72 | 7,502 |
| 2026-05-11 | Opipari Anthony W. See Remarks | Conversion · Series A Convertible Preferred Stock | −18,531 | 0 |
Page 3 of 4 · 79 trades